相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease
Rosalba Siracusa et al.
MOLECULAR NEUROBIOLOGY (2018)
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice
Marika Cordaro et al.
MOLECULAR NEUROBIOLOGY (2017)
Nrf2 mitigates LRRK2-and α-synuclein-induced neurodegeneration by modulating proteostasis
Gaia Skibinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury
Daniela Impellizzeri et al.
JOURNAL OF NEUROTRAUMA (2017)
2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation
Stefania Petrosino et al.
FRONTIERS IN PHARMACOLOGY (2017)
Nrf2: a modulator of Parkinson's disease?
Michael Todorovic et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation
Daniela Impellizzeri et al.
PHARMACOLOGICAL RESEARCH (2016)
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence
Carmen Avagliano et al.
PHARMACOLOGICAL RESEARCH (2016)
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation
Alison Ribeiro et al.
ACS CHEMICAL BIOLOGY (2015)
The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
Rosalba Siracusa et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease
Anna Hernandez-Aguilera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection
Sandeep Vasant More et al.
MOLECULAR NEURODEGENERATION (2015)
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
Patricia Rivera et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α
Longhe Yang et al.
SCIENTIFIC REPORTS (2015)
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
Yunjong Lee et al.
BMB REPORTS (2014)
Mast cells, glia and neuroinflammation: partners in crime?
Stephen D. Skaper et al.
IMMUNOLOGY (2014)
Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice
Friedrich Felix Hoyer et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations
Soeren V. Siegmund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells
H. Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration
Andrey S. Tsvetkov et al.
NATURE CHEMICAL BIOLOGY (2013)
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Maria C. Leal et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
The Role of Oxidative Stress in Parkinson's Disease
Vera Dias et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase
Yumiko Yamano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors
Cristina Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Microglia and mast cells: two tracks on the road to neuroinflammation
Stephen D. Skaper et al.
FASEB JOURNAL (2012)
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
Isabel Lastres-Becker et al.
HUMAN MOLECULAR GENETICS (2012)
Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice
Shigeki Moriguchi et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
Kang-Woo Lee et al.
PLOS ONE (2012)
Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
Emanuela Esposito et al.
PLOS ONE (2012)
Dopamine Transporter Loss in 6-OHDA Parkinson's Model Is Unmet by Parallel Reduction in Dopamine Uptake
Tanya Chotibut et al.
PLOS ONE (2012)
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
Stephen D. Skaper et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
α-Synuclein in Parkinson's Disease
Leonidas Stefanis
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease
Maria Cecilia Barone et al.
DISEASE MODELS & MECHANISMS (2011)
The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease
Kemal Ugur Tufekci et al.
PARKINSONS DISEASE (2011)
Effects of Hypericum Perforatum, in a rodent model of periodontitis
Irene Paterniti et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2010)
Cyclooxygenase and Neuroinflammation in Parkinson's Disease Neurodegeneration
Anna L. Bartels et al.
CURRENT NEUROPHARMACOLOGY (2010)
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role
Fernando Rodriguez-Sanabria et al.
JOURNAL OF MOLECULAR HISTOLOGY (2010)
Role of Nrf2 in Suppressing LPS-Induced Inflammation in Mouse Peritoneal Macrophages by Polyunsaturated Fatty Acids Docosahexaenoic Acid and Eicosapentaenoic Acid
Hu Wang et al.
MOLECULAR PHARMACEUTICS (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)
Natsuo Ueda et al.
PROGRESS IN LIPID RESEARCH (2010)
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival
Yong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in Mice
Narsa M. Reddy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Microglial Physiology: Unique Stimuli, Specialized Responses
Richard M. Ransohoff et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Parkinson's Disease: From Molecular Pathways in Disease to Therapeutic Approaches
Bobby Thomas
ANTIOXIDANTS & REDOX SIGNALING (2009)
Targets for neuroprotection in Parkinson's disease
Talene A. Yacoubian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model
Kyung Hee Jung et al.
JOURNAL OF PINEAL RESEARCH (2009)
Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice
Marco Bortolato et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
Carlos Solorzano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Angela B. Reksidler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice
Rong Hu et al.
CANCER LETTERS (2006)
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
Natalia Ferre et al.
JOURNAL OF HEPATOLOGY (2006)
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
RK Thimmulappa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease
HJ Choi et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons
AJ Herrera et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats
JC Perry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Nrf2-Keap1 defines a physiologically important stress response mechanism
H Motohashi et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Neuronal pathology in Parkinson's disease
JB Schulz et al.
CELL AND TISSUE RESEARCH (2004)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
DC Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway - Identification of novel gene clusters for cell survival
MK Kwak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M Sedelis et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues
MR D'Andrea et al.
NEUROSCIENCE LETTERS (2001)
Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages
T Ishii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
